Skip to main content
. Author manuscript; available in PMC: 2016 Aug 7.
Published in final edited form as: Brain Res. 2015 Apr 29;1616:10–18. doi: 10.1016/j.brainres.2015.04.045

Figure 1.

Figure 1

DAMGO antinociception in brain P450-deficient and control mice following icv administration. Control (WT) and Null mice of either sex were tested for nociceptive responses (time zero = baseline, BL), received DAMGO (0.1 nmol) or saline, and were re-tested at the indicated times (abscissa, min). Ordinate shows latencies (sec, mean ± S.E.M.) for the n values in parentheses. Data from both genders were pooled. **P < 0.01 vs. WT Saline at the same time. +, ++P < 0.05, 0.01, respectively vs. WT DAMGO at the same time.